期刊文献+

脑星形细胞瘤中P16、P53蛋白表达与病理组织学分级关系研究

Relationship between expression of P16 and P53 in brain astrocytoma with their grading of clinicopathological histology
暂未订购
导出
摘要 目的探讨P16和P53蛋白的表达与脑星形细胞瘤的病理组织学分级的关系。方法应用免疫组织化学技术SP法检测60例脑星形细胞瘤中P16和P53蛋白的表达情况。结果P16在脑星形细胞瘤的组织学分级Ⅲ、Ⅳ级与Ⅰ、Ⅱ级比较差异均有显著性(均P<0.05);P53在Ⅰ级脑星形细胞瘤中未见表达,与Ⅱ、Ⅲ、Ⅳ级比较差异有显著性,但Ⅱ、Ⅲ、Ⅳ级之间差异无显著性。结论P16、P53基因蛋白的表达与肿瘤的级别密切相关。 Objective To investigate the relationship between the expression of P16 and P53 in brain astrocytoma with their grading of pathological histology. Methods The expression of P16 and P53 was detected in 60 case of brain astrocytoma by S-P immunohistochemical technique. Results Among 60 brain astrocytoma,there was a significant difference between P16 and their grading of pathological histology ( P 〈 0.05 foreach ) , but the expression of P53 showed no difference in grade Ⅱ - Ⅲ, whereas there was significant difference between grade I and grade Ⅱ - Ⅳ. Conclusion The expression of P16 and P53 is closely correlated to histological grade of astrocytoma.
出处 《中国医药》 2006年第7期416-417,共2页 China Medicine
关键词 脑肿瘤 星形胶质细胞瘤 P16 P53 Brain neoplasms Astrocytoma P16 P53
  • 相关文献

参考文献2

二级参考文献20

  • 1张福林.1993年WHO的中枢神经系统肿瘤分类[J].临床神经科学,1995,3(1):7-7. 被引量:4
  • 2徐兆宗,张国胜,孙祥冬,史玉泉.对WHO中枢神经系统肿瘤新分类的理解[J].临床神经科学,1996,4(1):2-8. 被引量:4
  • 3黄文清.神经肿瘤病理学[M].上海:上海科学技术出版社,1982.322-323.
  • 4张福林.关于胶质瘤的命名和分类的几点建议[J].神经系统疾病,1978,1:4-4.
  • 5[2]Lewin KJ, Riddell RH, Weinstein WM, et al. Gastrointestinal pathology and its clinical implications. New York:Igaku-Shoin,1992:284~341.
  • 6[3]Mazur M, Clark HB. Gastric stromal tumors: Reappraisal of histogenesis. Am J Surg Pathol, 1983,7(6):507~19.
  • 7[4]Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumors of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology, 1994, 25(5):469~73.
  • 8[5]Miettinen M, Virolainen M, Sarlomo-Rikala M.Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Pathol, 1995,19(2):207~16.
  • 9[6]Hirota S, Isozaki K, Moriiyama Y, et al. Gain-of-function mutation of C-kit in human gastrointestinal stromal tumors. Science, 1998,279(5350):577~80.
  • 10[7]Hockenbery D, Nunez G, Millimen C, et al. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 1990,348(6229):334~6.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部